• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL CASHMERE 14 - CERECYTE MICROCOIL; NEUROVASCULAR EMBOLIZATION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL CASHMERE 14 - CERECYTE MICROCOIL; NEUROVASCULAR EMBOLIZATION DEVICE Back to Search Results
Catalog Number CRC14040830
Device Problems Positioning Failure (1158); Kinked (1339); Stretched (1601)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/02/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(6).The device was returned for analysis; however, the analysis has not yet been completed.Three attempts to obtain additional information were unsuccessful.Additional information will be submitted within 30 days of receipt.
 
Event Description
As reported by a healthcare professional, during the procedure, the cashmere coil (crc14040830/ s10006) could not be detached.They exchanged the coil to complete the procedure.There was no report of patient injury.
 
Manufacturer Narrative
Conclusion: as reported by a healthcare professional, during the procedure, the cashmere coil (crc14040830/ s10006) could not be detached.They exchanged the coil to complete the procedure.There was no report of patient injury.Multiple attempts to obtain additional information were unsuccessful.The cashmere was returned with its inner pouch.Labeling on the inner pouch matches the product documented in the complaint.The distal end of the embolic coil is located in the green introducer near its distal end.There appears to be blood on the embolic coil.The resheathing tool is broken.There is a kink in the device positioning unit (dpu) core wire at the strain relief and a bend approximately 2 cm from the strain relief.The ball tip is intact.The embolic coil is kinked in several locations and stretched.The articulating joint and resistance heating (rh) coil are obscured by the green introducer.However, the articulating joint appears to be damaged.There is blood visible in the green introducer and translucent introducer sheath.An attempt was made to advance the embolic coil out of the introducer to visualize the articulating joint and rh coil.The damaged embolic coil could not be advanced.While the resheathing tool is broken, its v-notch is undamaged.The resistance of the device was measured and the resistance was 52.8, which is within the specification range of 48.5  56.The device was connected to lab sample detachment control box (b)(4) with a standard connecting cable and the power was turned on.The system ready light illuminated.Detachment functionality cannot be tested because the embolic coil cannot be advanced out of the introducer.A review of manufacturing documentation associated with this lot presented no issues during the manufacturing or inspection processes related to the reported complaint.The complaint that the embolic coil failed to detach cannot be confirmed.While the embolic coil is attached to the dpu, and it passes the resistance test and causes the system ready light on the dcb to illuminate, the embolic coil cannot be advanced out of the introducer to test the detachment cycle.The kink and bend in the dpu core wire, broken resheathing tool, kinked embolic coil, and damaged articulating joint are all evidence that excessive force was applied to the device, possibly in an attempt to overcome resistance during advancement.The presence of blood in the green introducer and translucent introducer sheath suggests that an insufficient flush was maintained.The instructions for use (ifu) states that continuous infusion of an appropriate flush solution is optimal performance, and also indicates that the flush should be verified in the event of resistance.Insufficient flush allows blood to back-flow into the microcatheter, which can cause resistance.There is no current safety signal identified related to the reported event based on review of complaint history for the device.Since there was no evidence to suggest the event was related to a manufacturing issue, no corrective actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CASHMERE 14 - CERECYTE MICROCOIL
Type of Device
NEUROVASCULAR EMBOLIZATION DEVICE
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel
SZ 
Manufacturer Contact
karen anigbo
821 fox lane
san jose, CA 95131
5088288374
MDR Report Key6849322
MDR Text Key85628488
Report Number2954740-2017-00256
Device Sequence Number1
Product Code HCG
UDI-Device Identifier00878528004486
UDI-Public(01)00878528004486(17)210331(10)S10006
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K072173
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 08/21/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/07/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2021
Device Catalogue NumberCRC14040830
Device Lot NumberS10006
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/05/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/15/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/27/2016
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-